Canada Pension Plan Investment Board Eye Point Pharmaceuticals, Inc. Transaction History
Canada Pension Plan Investment Board
- $97.2 Billion
- Q4 2024
A detailed history of Canada Pension Plan Investment Board transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 50,700 shares of EYPT stock, worth $314,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,700
Previous 24,000
111.25%
Holding current value
$314,847
Previous $191,000
97.38%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
72.4MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$51.7 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$42.1 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$35.7 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$25.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$23.6 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $212M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...